C79.6 Secondary malignant neoplasm of ovary

Name of the Condition

• Secondary Malignant Neoplasm of Ovary
• ICD-10 Code: C79.6

Summary

Secondary malignant neoplasm of the ovary refers to cancer that has metastasized to the ovaries from a primary tumor located elsewhere in the body. This condition indicates the spread of an existing malignancy to the ovarian tissue and requires evaluation to identify the primary cancer source and guide management.

Causes

Secondary malignant neoplasms of the ovary arise when cancer cells from a primary tumor detach, travel through the bloodstream or lymphatic system, and establish new tumors in the ovaries. Common primary sites include the breast, gastrointestinal tract, or other organs with high metastatic potential.

Risk Factors

• History of primary cancer, particularly those with known ovarian metastatic patterns (e.g., breast, colorectal).
• Advanced stage of the primary tumor.
• Lack of effective treatment for the primary cancer.
• Weakened immune system.
• Genetic predisposition to aggressive cancer types.

Symptoms

• Abdominal or pelvic pain.
• Bloating or swelling in the abdomen.
• Changes in bowel or urinary habits.
• Unexplained weight loss or fatigue.
• Vaginal bleeding (postmenopausal or irregular).
• Palpable abdominal mass.

Diagnosis

Imaging tests (CT, MRI, or PET scans) are used to detect metastatic lesions in the ovaries. Biopsy of ovarian tissue confirms the presence of cancer cells and determines their origin. Blood tests may assess tumor markers or organ function.

Treatment Options

• Chemotherapy: Targets cancer cells throughout the body, often based on the primary tumor type.
• Hormone therapy: May be used if the primary cancer is hormone-sensitive.
• Surgery: To remove ovarian tumors or manage symptoms, depending on the extent of disease.
• Palliative care: Focuses on symptom relief and quality of life for advanced cases.

Prognosis and Follow-Up

Prognosis depends on the primary cancer type, extent of metastasis, and treatment response. Regular follow-up with imaging and clinical evaluations is essential to monitor for recurrence or progression. Survival rates vary based on individual factors.

Complications

• Bowel obstruction or perforation.
• Ascites (fluid buildup in the abdomen).
• Ovarian torsion (rare).
• Metastasis to other organs.
• Treatment-related side effects (e.g., chemotherapy toxicity).

Lifestyle & Prevention

• Maintain a healthy weight and balanced diet.
• Avoid tobacco and limit alcohol.
• Engage in regular physical activity.
• Follow recommended cancer screening for primary sites (e.g., breast, colon).
• Discuss risk-reduction strategies with a healthcare provider if you have a history of primary cancer.

When to Seek Professional Help

Seek medical attention if you experience persistent abdominal pain, bloating, unexplained weight loss, or abnormal vaginal bleeding. Prompt evaluation is critical for early detection and management of metastatic disease.

Tips for Medical Coders

Document the underlying primary cancer and any relevant details about the ovarian metastasis, such as laterality or specific histology, when available. Ensure the code C79.6 is used only when the ovary is a secondary site, not the primary origin of the malignancy. Verify that the diagnosis aligns with clinical findings and imaging results to support accurate coding.